Cholangiocarcinoma other imaging findings: Difference between revisions
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) |
||
Line 16: | Line 16: | ||
[[Endoscopic ultrasound]] can also be performed at the time of ERCP and may increase the accuracy of the biopsy and yield information on [[lymph node]] invasion and operability.<ref>{{cite journal |author=Sugiyama M, Hagi H, Atomi Y, Saito M |title=Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography |journal=Abdom Imaging |volume=22 |issue=4 |pages=434-8 |year= |id=PMID 9157867}}</ref> | [[Endoscopic ultrasound]] can also be performed at the time of ERCP and may increase the accuracy of the biopsy and yield information on [[lymph node]] invasion and operability.<ref>{{cite journal |author=Sugiyama M, Hagi H, Atomi Y, Saito M |title=Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography |journal=Abdom Imaging |volume=22 |issue=4 |pages=434-8 |year= |id=PMID 9157867}}</ref> | ||
===Percutaneous Transhepatic Cholangiography | ===Percutaneous Transhepatic Cholangiography=== | ||
As an alternative to ERCP, [[percutaneous transhepatic cholangiography]] (PTC) may be utilized. | |||
===Direct Cholangiography=== | ===Direct Cholangiography=== | ||
Direct cholangiography is a blanket term for any imaging obtained with intra-biliary tree contrast, and includes: | |||
PTC | |||
ERCP | |||
CT IVC | |||
MRCP | |||
All these modalities not only allow evaluation of the the biliary tree, but are invaluable in planning treatment as assessing for resectability. | |||
===[[Magnetic resonance cholangiopancreatography]] (MRCP)=== | ===[[Magnetic resonance cholangiopancreatography]] (MRCP)=== | ||
*[[Non-invasive]] alternative to ERCP.<ref>{{cite journal |author=Schwartz L, Coakley F, Sun Y, Blumgart L, Fong Y, Panicek D |title=Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography |journal=AJR Am J Roentgenol |volume=170 |issue=6 |pages=1491–5 |year=1998 |id=PMID 9609160}}</ref> | *[[Non-invasive]] alternative to ERCP.<ref>{{cite journal |author=Schwartz L, Coakley F, Sun Y, Blumgart L, Fong Y, Panicek D |title=Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography |journal=AJR Am J Roentgenol |volume=170 |issue=6 |pages=1491–5 |year=1998 |id=PMID 9609160}}</ref><ref>{{cite journal |author=Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G |title=Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures |journal=Gut |volume=46 |issue=1 |pages=103-6 |year=2000 |id=PMID 10601064}}</ref><ref>{{cite journal |author=Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E |title=Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography |journal=World J Surg |volume=27 |issue=3 |pages=278-83 |year=2003 |id=PMID 12607051}}</ref> | ||
*More accurately define the tumor and avoids the risks of ERCP <ref>{{cite journal |author=Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M |title=Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings |journal=Am J Gastroenterol |volume=95 |issue=2 |pages=432-40 |year=2000 |id=PMID 10685746}}</ref><ref>{{cite journal |author=Freeman M, Sielaff T |title=A modern approach to malignant hilar biliary obstruction |journal=Rev Gastroenterol Disord |volume=3 |issue=4 |pages=187–201 |year=2003 |id=PMID 14668691}}</ref> | *More accurately define the tumor and avoids the risks of ERCP <ref>{{cite journal |author=Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M |title=Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings |journal=Am J Gastroenterol |volume=95 |issue=2 |pages=432-40 |year=2000 |id=PMID 10685746}}</ref><ref>{{cite journal |author=Freeman M, Sielaff T |title=A modern approach to malignant hilar biliary obstruction |journal=Rev Gastroenterol Disord |volume=3 |issue=4 |pages=187–201 |year=2003 |id=PMID 14668691}}</ref> | ||
Revision as of 16:44, 31 January 2018
Cholangiocarcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cholangiocarcinoma other imaging findings On the Web |
American Roentgen Ray Society Images of Cholangiocarcinoma other imaging findings |
Risk calculators and risk factors for Cholangiocarcinoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Other imaging studies for cholangiocarcinoma include endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, percutaneous transhepatic cholangiography, and MRCP.
ERCP
While abdominal imaging can be useful in the diagnosis of cholangiocarcinoma, direct imaging of the bile duct is often necessary. Endoscopic retrograde cholangiopancreatography (ERCP) has been widely used for this purpose. Although ERCP is an invasive procedure with attendant risks, its advantages include:
- Determine if there is a bile duct tumor and obtain a biopsy to look for cancer cells
- Observe if cancer has spread from the bile ducts
- Help plan surgery
- Place a small tube (stent) into the bile duct to relieve a blockage caused by a tumor
Endoscopic Ultrasound
Endoscopic ultrasound can also be performed at the time of ERCP and may increase the accuracy of the biopsy and yield information on lymph node invasion and operability.[1]
Percutaneous Transhepatic Cholangiography
As an alternative to ERCP, percutaneous transhepatic cholangiography (PTC) may be utilized.
Direct Cholangiography
Direct cholangiography is a blanket term for any imaging obtained with intra-biliary tree contrast, and includes: PTC ERCP CT IVC MRCP All these modalities not only allow evaluation of the the biliary tree, but are invaluable in planning treatment as assessing for resectability.
Magnetic resonance cholangiopancreatography (MRCP)
- Non-invasive alternative to ERCP.[2][3][4]
- More accurately define the tumor and avoids the risks of ERCP [5][6]
References
- ↑ Sugiyama M, Hagi H, Atomi Y, Saito M. "Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography". Abdom Imaging. 22 (4): 434–8. PMID 9157867.
- ↑ Schwartz L, Coakley F, Sun Y, Blumgart L, Fong Y, Panicek D (1998). "Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography". AJR Am J Roentgenol. 170 (6): 1491–5. PMID 9609160.
- ↑ Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G (2000). "Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures". Gut. 46 (1): 103–6. PMID 10601064.
- ↑ Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E (2003). "Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography". World J Surg. 27 (3): 278–83. PMID 12607051.
- ↑ Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M (2000). "Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings". Am J Gastroenterol. 95 (2): 432–40. PMID 10685746.
- ↑ Freeman M, Sielaff T (2003). "A modern approach to malignant hilar biliary obstruction". Rev Gastroenterol Disord. 3 (4): 187–201. PMID 14668691.